| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/28/2001 | US6280720 Integrant of bacillus thuringiensis or spore thereof which produces homologous or heterologous crystal delta-endotoxin, having greater pesticidal activity than corresponding parental strain by producing larger quantity of endotoxin |
| 08/28/2001 | US6280590 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis |
| 08/28/2001 | US6280500 Methods for removing pollutants from contaminated soil materials with a fern plant |
| 08/28/2001 | CA2333930A1 Dna sequence encoding the specific and antigenic outer membrane protein of s amonella typhi |
| 08/28/2001 | CA2203443C Hepatitis c virus asialoglycoproteins |
| 08/28/2001 | CA2173872C Telomerase activity assays |
| 08/28/2001 | CA2030554C Mutant microbial .alpha.-amylases with increased thermal, acid, and/or alkaline stability |
| 08/28/2001 | CA1341287C Polypeptides derived from human papillomavirus, antibodies to said polypeptide and detection of human papillomavirus latent proteins |
| 08/28/2001 | CA1341286C Blood substitutes |
| 08/24/2001 | CA2338138A1 A method for production of a transgenic animal, and a transgenic animal produced by the method |
| 08/23/2001 | WO2001061356A1 Her-2 binding antagonists |
| 08/23/2001 | WO2001061355A1 Molecular impriniting compositions and methods for binding and analyzing macromolecules |
| 08/23/2001 | WO2001061354A1 Compositions and methods for surface imprinting |
| 08/23/2001 | WO2001061350A1 Methods and compositions for identifying ligands for nuclear receptors |
| 08/23/2001 | WO2001061346A2 Methods for identifying agents causing a lethal phenotype |
| 08/23/2001 | WO2001061055A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/23/2001 | WO2001061052A1 Dna arrays for determining drug selectivity |
| 08/23/2001 | WO2001061049A1 Altered recombinases for genome modification |
| 08/23/2001 | WO2001061046A2 HUMAN VNO cDNA LIBRARIES |
| 08/23/2001 | WO2001061042A2 Composite membranes for assaying biomolecules |
| 08/23/2001 | WO2001061041A2 Multiple-site reaction device and method |
| 08/23/2001 | WO2001061040A1 Microarray methods utilizing semiconductor nanocrystals |
| 08/23/2001 | WO2001061039A2 5-hydroxytryptamine transporter gene polymorphisms |
| 08/23/2001 | WO2001061038A2 Method for detecting a biological entity in a sample |
| 08/23/2001 | WO2001061037A1 Methods and kits for proximity probing |
| 08/23/2001 | WO2001061030A2 LIBRARIES OF OPTIMUM SUBSEQUENCE REGIONS OF mRNA AND GENOMIC DNA FOR CONTROL OF GENE EXPRESSION |
| 08/23/2001 | WO2001061025A1 Method for increasing the gene expression of transfected genes |
| 08/23/2001 | WO2001061024A2 Rolling circle replicon expression vectors |
| 08/23/2001 | WO2001061023A1 Reduction of in planta degradation of recombinant plant products |
| 08/23/2001 | WO2001061022A1 Recombinant human papillomavirus vaccine expressed in transgenic plants |
| 08/23/2001 | WO2001061021A2 Transgenic plants having resistance to a fungal disease |
| 08/23/2001 | WO2001061020A2 Alteration of growth and adaptation under hypoxic conditions |
| 08/23/2001 | WO2001061019A2 A dominant selectable marker for gene transformation and disruption in yeasts |
| 08/23/2001 | WO2001061018A1 Method of selecting transformant with high expression of target protein |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001061016A2 Human kinases and polynucleotides encoding the same |
| 08/23/2001 | WO2001061015A2 Thermostable chimeric nucleic acid polymerases and uses thereof |
| 08/23/2001 | WO2001061014A1 (r)-2-octanol dehydrogenase, process for producing the enzyme, dna encoding the enzyme and process for producing alcohol by using the same |
| 08/23/2001 | WO2001061013A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 08/23/2001 | WO2001061012A1 A method for generating hypermutable plants |
| 08/23/2001 | WO2001061011A2 Human thrombospondin repeat proteins and polynucleotides encoding the same |
| 08/23/2001 | WO2001061010A2 Gtpase activating proteins |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001061006A2 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 08/23/2001 | WO2001061005A2 Molecules of the pyrin domain protein family and uses thereof |
| 08/23/2001 | WO2001061004A1 Novel protein having signal sequence |
| 08/23/2001 | WO2001061003A1 The human homologue of flamingo |
| 08/23/2001 | WO2001061002A1 Control of membrane traffic |
| 08/23/2001 | WO2001061001A2 Novel, central nervous protein, that modulates k+ flows |
| 08/23/2001 | WO2001061000A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof |
| 08/23/2001 | WO2001060998A2 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | WO2001060997A2 Male tissue-specific regulatory region and method of using same |
| 08/23/2001 | WO2001060996A1 Method of controlling telomere length |
| 08/23/2001 | WO2001060995A1 Cell fusion assays using fluorescence resonance energy transfer |
| 08/23/2001 | WO2001060993A1 Bacterial isolates of the genus klebsiella, and an isomaltulose synthase gene isolated therefrom |
| 08/23/2001 | WO2001060992A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060990A2 Sphingosine kinases |
| 08/23/2001 | WO2001060984A1 Immortalized vascular adventitial cell line |
| 08/23/2001 | WO2001060983A2 Treatment for bone disorders |
| 08/23/2001 | WO2001060982A1 Genetically engineered skin cell types and toxicity assays |
| 08/23/2001 | WO2001060980A1 Transgenic, non-human animals containing a coxsackie/adenovirus receptor (car) |
| 08/23/2001 | WO2001060978A2 In ovo activation of an avian egg in the shell |
| 08/23/2001 | WO2001060975A2 Gene disruption methodologies in fungi for drug target discovery |
| 08/23/2001 | WO2001060970A2 Zinc finger domains and methods of identifying same |
| 08/23/2001 | WO2001060890A2 Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof |
| 08/23/2001 | WO2001060866A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein |
| 08/23/2001 | WO2001060859A1 Novel proteins and novel genes encoding the same |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060855A1 A novel human cell cycle control-related protein and a sequence encoding the same |
| 08/23/2001 | WO2001060854A1 Novel members of the h+/oligopeptide transporter gene family |
| 08/23/2001 | WO2001060853A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | WO2001060852A1 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF |
| 08/23/2001 | WO2001060850A1 Novel compounds |
| 08/23/2001 | WO2001060849A2 Cold-adapted equine influenza viruses |
| 08/23/2001 | WO2001060847A2 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060838A2 Aids ancestral viruses and vaccines |
| 08/23/2001 | WO2001060794A2 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 08/23/2001 | WO2001060769A1 Segment synthesis |
| 08/23/2001 | WO2001060517A2 Container for nucleic acid analysis |
| 08/23/2001 | WO2001060413A2 Recombinant vector expressing a beta2-adrenergic receptor and use in treating airway and vascular diseases |
| 08/23/2001 | WO2001060403A1 Gm-negative ehv-mutants |
| 08/23/2001 | WO2001060397A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | WO2001060152A2 Transgenic non-human ucp2 knockout mammal |
| 08/23/2001 | WO2001060151A1 Mdel rats with the onset of prostatic cancer |
| 08/23/2001 | WO2001025793A3 Diagnosis of coeliac disease using a gliadin epitope |
| 08/23/2001 | WO2001025422A3 Antisense compositions and cancer-treatment methods |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001023082A3 Biomolecular attachment sites on microelectronic arrays |
| 08/23/2001 | WO2001016326A3 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (PFEMP1) that mediates adhesion to chondroitin sulfate A |
| 08/23/2001 | WO2001012827A3 Method for production of transgenic plants with increased tocopherol content |
| 08/23/2001 | WO2001012799A3 Regulatory sequences for pollen specific or pollen abundant gene expression in plants |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001012215A3 Protective antigen of Epstein barr virus |
| 08/23/2001 | WO2001011060A3 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 08/23/2001 | WO2001010907A3 Therapeutic polypeptides and methods for using same |
| 08/23/2001 | WO2001010892A3 Peptide antagonists of factor VIIA |